PIK3CA and adenocarcinoma: DiMarco et al. (July 2025) built the first RIT1 M90I mouse model that formed adenocarcinomas resembling human disease and showed RIT1-mutant cells are vulnerable to inhibitors of MAPK, PI3K, and cholesterol biosynthesis.